12.7
View the full transcript and gain access to JoVE Core videos
Q1: What are multiple alleles and how do they differ from typical alleles?
Multiple alleles occur when a gene exists in three or more allelic forms within a population, though diploid organisms like humans carry only two alleles per gene. For example, the beta-globin gene has several alleles including the normal allele and the sickle allele. Blood type demonstrates multiple allelism with three alleles: IA, IB, and i. These multiple forms allow for greater genetic diversity and varied phenotypic expression.
Q2: How does incomplete dominance differ from complete dominance in sickle cell trait?
In incomplete dominance, heterozygotes display an intermediate phenotype between homozygotes. Sickle cell heterozygotes produce both normal disc-shaped and sickle-shaped red blood cells, showing mildly curved cells especially under low oxygen. This contrasts complete dominance, where heterozygotes would display only the dominant phenotype. The intermediate phenotype of sickle cell trait heterozygotes exemplifies incomplete dominance at the cellular level.
Q3: What is codominance and how does it appear in sickle cell heterozygotes?
Codominance occurs when both alleles are fully expressed in heterozygotes, producing roughly equal quantities of both protein products. In sickle cell heterozygotes, normal hemoglobin and sickle hemoglobin proteins occur in equal amounts, so both alleles are expressed simultaneously. Blood type also demonstrates codominance: IAIB heterozygotes express both A and B antigens on red blood cell surfaces, showing both phenotypes together.
Q4: Why do sickle cell homozygotes experience more severe symptoms than heterozygotes?
Sickle cell homozygotes produce only sickle hemoglobin, causing all red blood cells to become stiff and crescent-shaped, leading to vessel clogging and serious complications. Heterozygotes produce both normal and sickle hemoglobin in equal quantities, resulting in a mixture of cell shapes that rarely cause complications unless exposed to low oxygen conditions. The presence of normal hemoglobin in heterozygotes provides protective benefit.
Q5: How do allele interactions at the molecular level explain phenotypic outcomes?
Molecular-level allele interactions determine protein production patterns that directly influence cellular phenotypes. In sickle cell heterozygotes, codominance at the molecular level produces equal amounts of normal and sickle hemoglobin proteins, resulting in incomplete dominance at the cellular level with mixed red blood cell shapes. Understanding these molecular interactions helps researchers explain disease complications and develop improved treatments for conditions like sickle cell trait.
Q6: What role does the beta-globin gene play in determining red blood cell shape?
The beta-globin gene encodes hemoglobin protein components that directly influence red blood cell morphology. The normal allele produces flexible hemoglobin allowing disc-shaped erythrocytes to travel easily through blood vessels. The sickle allele produces hemoglobin that polymerizes and sticks together, causing rigid crescent-shaped cells. Different alleles of this gene create distinct phenotypic outcomes affecting oxygen transport and overall health.
Q7: How can studying allele interactions improve treatment of genetic diseases?
By examining allele interactions at molecular and cellular levels, researchers understand how different alleles produce specific phenotypes and disease complications. This knowledge enables targeted interventions addressing the underlying mechanisms of conditions like sickle cell trait. Understanding whether a condition involves incomplete dominance, codominance, or other allele interactions helps clinicians predict severity, identify at-risk populations through pedigree analysis and disease inheritance patterns, and develop more effective therapies.
Explore Related Chapters



































